Germany tightens grip on misconduct...

Article Abstract:

The Max Planck Society of Germany plans to teach scientific ethics to young researchers and has brought in a new internal regulatory system for handling alleged scientific misconduct cases. The society operates 73 research institutes and primarily hopes to prevent misconduct rather than catch perpetrators. The ethics programme will probably include lessons on the acknowledgment of technical contributors, authorship and the appropriate ways to maintain science notebooks. The Deutsche Forschungsgemeinschaft grant-giving organization is also focusing on fraud prevention following a major case.

Author: Abbott, Alison
Prevention, Ethical aspects, Study and teaching, Ethics, Fraud in science, Science fraud, Max Planck Society for the Advancement of Science

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Europe tightens rules that govern homeopathic products

Article Abstract:

The European Parliament has toughened the regulation of homeopathy, a form of alternative medicine that relies on the allegedly therapeutic powers of highly dilute products. The new rules repeal the homeopathic products' exemption from ordinary pharmacological standards that was approved in 1991 and require instead that such products be licensed as other drugs are. However, the European Federation of Pharmacology Societies criticized the Parliament for putting homeopathy in too favorable a light by labeling its products 'medicines' rather than 'preparations.'

Author: Abbott, Alison
Homeopathy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Biotech industry woos MEPs to ease regulatory burden

Article Abstract:

The biotechnology industry in Europe is trying to win the favor of the Members of European Parliament (MEPs) to reduce regulations on the industry regarding patenting of biotechnological products. The Forum for European Bioindustry Coordination wants the approval of the MEPs for the patenting of human genes, and transgenic animals and plants. The industry is aware that the parliament's sensitivity towards public opinion regarding patenting of genes will be a crucial factor in the relaxation of its regulatory burden.

Author: Abbott, Alison
Biotechnology industry, Biotechnology industries, Biological products, Intellectual property

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Laws, regulations and rules, Science and technology policy, European Union. European Parliament
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.